Oklahoma legislation · 2026 Regular Session
Oklahoma HB3130: Gender transition procedures; health services for minors; definition; referrals and aiding and abetting; punitive damages; exempting immunity protection for employees in certain actions; emergency.
Status: In committee, April 1, 2026
What the bill says
An Act relating to gender transition procedures; amending Section 1, Chapter 150, O.S.L. 2023 (63 O.S. Supp. 2025, Section 2607.1), which relates to health services for minors; clarifying definition; providing definition; including referrals and aiding and abetting; providing for no limitation on punitive damages; exempting immunity protection for employees in certain actions; providing for codification; and declaring an emergency.
From the engrossed text, March 30, 2026:
An Act relating to gender transition procedures; amending Section 1, Chapter 150, O.S.L. 2023 (63 O.S. Supp. 2025, Section 2607.1), which relates to health services for minors; clarifying definition; providing definition; including referrals and aiding and abetting; providing for no limitation on punitive damages; exempting immunity protection for employees in certain actions; providing for codification; and declaring an emergency. BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: SECTION 1. AMENDATORY Section 1, Chapter 150, O.S.L. 2023 (63 O.S. Supp. 2025, Section 2607.1), is amended to read as follows: Section 2607.1. A. As used in this section: 1. "Child" or "minor" means any person under eighteen (18) years of age; 2. a. "Gender transition procedures" means the following medical or surgical services performed for the purpose of attempting to affirm the minor's perception of his ENGR. H. B. NO. 3130 Page or her gender or biological sex, if that perception is inconsistent with the minor's biological sex: (1) surgical procedures that alter or remove physical or anatomical characteristics or features that are typical for the individual's biological sex, including, but not limited to, genital or chest surgeries, or (2) puberty-blocking drugs, cross-sex hormones, or other drugs to suppress or delay normal puberty or to promote the development of feminizing or masculinizing features consistent with the opposite biological sex. …